India's national Atomic Energy Regulation Board (AERB) has approved GVK Biosciences to perform certain isotope-labeling research in its facility, according to the Hyderabad-based contract research organization (CRO).
UK Government proposals to hand oversight of tissue handling to a non-specialist body would have a negative impact on the preclinical services sector says the Human Tissue Authority.
Charles River Laboratories' deal with AstraZeneca may only formalise an existing relationship but a second Big Pharma accord is good news for the CRO say analysts.
Preclinical CRO Bioanalytical Systems (BASi) saw revenue, margins and gross profits fall during its fiscal third quarter but the firm is positive about the impact of recent restructuring efforts.
AstraZeneca and Assay Depot have launched a new “virtual research lab” which they say will allow a small group of scientists to run full drug discovery from a laptop.
US Preclinical CRO Ricerca has launched two new assay services one of which is designed to help assess the risk a biologic drug will induce a cytokine storm.
Covance has reported a net loss of $12.7m in this year’s Q2 as what it says is the result of facility closures and restructuring costs, particularly for its early phase development section.
BioFocus has taken on Titian’s sample management software in a bid to pump more resources into “refreshing” its 900,000 strong high-throughput screening (HTS) compound portfolio.
The US FDA has updated its preclinical testing requirements for biotech drugs citing advances since the publication of ICH S6 and the need to harmonize with international standards.
SNBL USA has invested in ‘social housing’ at its lab in Everett, Washington citing ‘recent reductions’ in US non-human primate lab capacity as the driver.
Preclinical services firm SNBL has fixed most of the deficiencies observed during a US FDA inspection in 2010 and says it is working to ‘quickly’ resolve the remaining issues.
MPI Research must reconfigure its enclosures after they led to the death of a non-human primate, a USDA report obtained by animal rights activists shows.
Australian preclinical CRO vivoPharm has bought toxicology testing firm RMIT Drug Discovery Technologies (RDDT) and will relocated to a new Melbourne HQ.
